Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
15.44
+0.47 (3.14%)
Nov 22, 2024, 4:00 PM EST - Market closed
Progyny Revenue
Progyny had revenue of $286.63M in the quarter ending September 30, 2024, with 2.04% growth. This brings the company's revenue in the last twelve months to $1.14B, up 10.24% year-over-year. In the year 2023, Progyny had annual revenue of $1.09B with 38.34% growth.
Revenue (ttm)
$1.14B
Revenue Growth
+10.24%
P/S Ratio
1.26
Revenue / Employee
$2,011,890
Employees
566
Market Cap
1.31B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AdaptHealth | 3.26B |
Pediatrix Medical Group | 2.01B |
Novavax | 885.19M |
STAAR Surgical Company | 341.22M |
Maravai LifeSciences Holdings | 276.92M |
Arcus Biosciences | 263.00M |
Ardelyx | 251.85M |
Aurinia Pharmaceuticals | 220.36M |
PGNY News
- 5 days ago - Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders - GlobeNewsWire
- 5 days ago - Progyny: After A Terrible Year, I'm Out (Rating Downgrade) - Seeking Alpha
- 9 days ago - Progyny, Inc. to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 10 days ago - These Analysts Slash Their Forecasts On Progyny Following Q3 Results - Benzinga
- 10 days ago - Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Progyny, Inc. Announces Third Quarter 2024 Results - GlobeNewsWire
- 15 days ago - Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman - GlobeNewsWire
- 25 days ago - Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report - GlobeNewsWire